Vela Labs GmbH

VelaLabs was founded in 2006 in the former Novartis Campus in Vienna. Since 2007, it is a GMP-certified service-oriented company with focus on analytical and quality control of biopharmaceutical products, as well as clinical development of biosimilars, biologics and ATMPs. By the acquisition of LABH in 2019, VelaLabs can now also offer all types of microbiological services. Together with its strong team, the VelaLabs Management aims to successfully realize its vision of the future and expand its base of operations.

Among the new goals are digitalization and expansion of its analytical method portfolio for innovative products, as well as GLP certification.

Our philosophy is to support our customers during the journey through the adventure of health.

With our help you have a competent partner in your side for the whole process of drug development that supports you with analytical development, clinical expertise and regulatory consulting.

VelaLabs stands for individual customer support, highest quality standards and professional expertise and we are an international partner for the pharma and biotechnology industry developing biopharmaceuticals and biosimilars.

Our solutions are not out-of-the-box and our flexible and dynamic team can provide tailored solutions for our customers while also having regulatory expertise.